Position in ARGX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$63,088
+$13,431 QoQ
Shares Held
68
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#396
of 504 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MATHER GROUP, LLC. holds $3,776,661 across 27 Biotechnology names. ARGX ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,516 | $2,243,232 | |
| 2 | MRNA |
Moderna, Inc.
|
7,604 | $532,508 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
791 | $493,220 | |
| 4 | INCY |
Incyte Corp
|
1,019 | $115,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,367 | $78,219 | |
| 6 | ARGX |
Argenx SE
This page
|
68 | $63,088 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
130 | $41,091 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
73 | $39,197 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,088 | 68 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $49,657 | 68 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $50,154 | 68 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $58,594 | 99 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $60,885 | 99 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $53,665 | 99 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $42,143 | 98 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $38,978 | 99 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||